Insider Transactions in Q4 2022 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+0.71%
|
$21,000
$3.67 P/Share
|
|
Dec 22
2022
|
Jeffrey Eisele Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
89
-0.28%
|
$4,539
$51.68 P/Share
|
|
Dec 19
2022
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,200
-1.42%
|
$1,466,400
$52.02 P/Share
|
|
Dec 19
2022
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,888
+1.66%
|
$349,216
$7.13 P/Share
|
|
Dec 15
2022
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.47%
|
$65,000
$52.35 P/Share
|
|
Dec 15
2022
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.47%
|
$2,500
$2.67 P/Share
|
|
Dec 08
2022
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.22%
|
$564,000
$47.5 P/Share
|
|
Dec 08
2022
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.85%
|
$37,000
$2.67 P/Share
|
|
Dec 05
2022
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.44%
|
$250,000
$50.38 P/Share
|
|
Dec 05
2022
|
Adam J. Townsend Chief Commercial Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
5,000
-9.45%
|
$75,000
$15.09 P/Share
|
|
Dec 01
2022
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.5%
|
$122,500
$49.93 P/Share
|
|
Dec 01
2022
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Direct |
500
-0.38%
|
$24,500
$49.93 P/Share
|
|
Nov 15
2022
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.47%
|
$60,000
$48.01 P/Share
|
|
Nov 15
2022
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.47%
|
$2,500
$2.67 P/Share
|
|
Nov 08
2022
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.23%
|
$552,000
$46.47 P/Share
|
|
Nov 08
2022
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.86%
|
$37,000
$2.67 P/Share
|
|
Nov 03
2022
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.44%
|
$290,000
$58.54 P/Share
|
|
Nov 03
2022
|
Adam J. Townsend Chief Commercial Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
5,000
-9.45%
|
$75,000
$15.09 P/Share
|
|
Nov 01
2022
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.44%
|
$150,000
$60.83 P/Share
|
|
Nov 01
2022
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Direct |
500
-0.38%
|
$30,000
$60.83 P/Share
|
|
Oct 26
2022
|
Victoria L. Brown Program Team Lead |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.52%
|
$7,540
$58.41 P/Share
|
|
Oct 20
2022
|
James George Chopas VP/Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.7%
|
$7,540
$58.0 P/Share
|
|
Oct 20
2022
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
196
-0.67%
|
$11,368
$58.0 P/Share
|
|
Oct 14
2022
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.47%
|
$73,750
$59.31 P/Share
|
|
Oct 14
2022
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.47%
|
$2,500
$2.67 P/Share
|
|
Oct 10
2022
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.24%
|
$684,000
$57.5 P/Share
|
|
Oct 10
2022
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.87%
|
$37,000
$2.67 P/Share
|
|
Oct 03
2022
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.38%
|
$165,000
$66.69 P/Share
|
|
Oct 03
2022
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.44%
|
$330,000
$66.69 P/Share
|
|
Oct 03
2022
|
Adam J. Townsend Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.45%
|
$75,000
$15.09 P/Share
|